Prevention of multiple organ dysfunction syndrome in septic abdominal surgery patients with melatonin

Phase 2 trial of melatonin in sepsis and multiple organ dysfunction syndrome (MODS), sponsored by Hospital Universitario Virgen de las Nieves. Primary endpoints: Inflammatory and immunological response over early postoperative period and Incidence of multiple organ dysfunction syndrome (MODS). Started May 2013; status: active.